期刊文献+

替莫唑胺同步放疗治疗非小细胞肺癌脑转移32例观察 被引量:7

下载PDF
导出
摘要 脑是体内各种恶性肿瘤发生远处转移时最常累及的器官之一,主要是由于大脑血流量大,而大脑皮层血管腔较小,血液中恶性肿瘤细胞易停留并生长。非小细胞肺癌脑转移系晚期肺癌的常见表现,约占全部肺癌的50%,自然病程一般在3~5个月以内嘲。以往非小细胞肺癌脑转移化疗由于受到血脑屏障和化疗药物敏感性的限制,联合放疗的化疗药物不多且疗效不佳。
出处 《云南医药》 CAS 2009年第3期374-375,共2页 Medicine and Pharmacy of Yunnan
  • 相关文献

参考文献9

  • 1RODRIGUS P, DE-BROUWER P, RAAYMAKERS E,et al. Brain metastasis and non-small cell lung cancer. Prognosis factors and correlation with survival after irradiation[J].Lung Cancer, 2001,32 (2) :129-136.
  • 2SHEEHAN JP, SUN MH, KONDZIOLKA D, et al. Radiosurgery for non-small cell lung carcinoma metastasis to the brain: Long-term outcomes and prognosis factors influencing patient survival time and local tumor control [J].Neurosurg, 2002,97 (6) :1281-1296.
  • 3庞华,张君仁,赵丽.替莫唑胺的合成及抗肿瘤活性[J].中国医药工业杂志,2003,34(2):53-55. 被引量:14
  • 4杨宁蓉,王琳,秦叔逵.替莫唑胺治疗原发性中枢神经系统恶性淋巴瘤1例[J].临床肿瘤学杂志,2007,12(11):880-880. 被引量:3
  • 5RENI M, ZAJA F, MASON W,et al.Temozolomide as salvage treatment in primary brain lymphomas[J].Br Caner,2007,96 (6):864-867.
  • 6KOUROUSSIS C, VAMVAKAS L, VARDAKIS N,et al.Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase Ⅱ study[J].Oncology,2009,76(2): 112-117.
  • 7GIORGIO CG, GIUFFRIDA D, PAPPALARDO A,et al.Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase Ⅱ study[J].Lung Cancer, 2005,50(2):247-254.
  • 8KOUVARIS JR, MILIADOU A, KOULOULIAS VE, et al. Phase Ⅱ study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors[J]. Onkologie,2007,30(7):350-351.
  • 9谢家印,向德兵,王阁,杨镇洲,李毅,余娴,罗唯,王东.替莫唑胺联合全脑放疗治疗非小细胞肺癌脑转移临床研究[J].重庆医学,2007,36(19):1941-1942. 被引量:20

二级参考文献4

共引文献34

同被引文献63

  • 1施为建,王科明.GP-T方案治疗非小细胞肺癌合并脑转移的初步报告[J].临床肿瘤学杂志,2004,9(5):509-510. 被引量:1
  • 2陈绍水,宁方玲,赵磊,吕俊华,于泽顺,纪春祥.放化疗同步治疗肺癌脑转移38例临床分析[J].肿瘤防治杂志,2005,12(19):1502-1504. 被引量:1
  • 3杨万毅,陈绪元.肺癌脑转移的治疗进展[J].重庆医学,2006,35(12):1133-1136. 被引量:6
  • 4Sheehan JP,Sun Mh,Kondziolka D,et al.Radio surgery for nonsmall cell lung carcinoma metastasis to the brain:Long term outcomes and prognosis factors influencing patient survival time and local tumor control[J].Neurosurg.2002,97(6):1281-1296.
  • 5Christodoulou C,Bafaloukos D,Kosmidis P,et al.Phase Ⅱ study of temozolomide in heavily pretreated cancer patients with brain metastases[J].Ann Oncol.2001,12:249-254.
  • 6Dardoufas C,Miliadou A,Skarleas C,et al.Concomitant temozolomide(TMZ)and radiotherapy(RT)followed by adjuvant treatment with temozolomide in patients with brain metastases from solid tumours[J].Proc Am Soc Clin Oncol.2001,20:75b.Abstract 2048.
  • 7Omuro AMP,Raizer JJ,Abrey.A phase Ⅰ trial of temozolomide and vinorelbine in patients with recurrent brain metastases[J].Clin Oncol.2004 ASCO Annual Meeting.
  • 8Christodoulou C,Bafaloukos D,Kosmidis P,et al.Phase Ⅱ study of temozolomide in heavily pretreated cancer patients with brain metastases.Ann Oncol,2001,12 (2):249-254.
  • 9谢家印,向德兵,王阁,杨镇洲,李毅,余娴,罗唯,王东.替莫唑胺联合全脑放疗治疗非小细胞肺癌脑转移临床研究[J].重庆医学,2007,36(19):1941-1942. 被引量:20
  • 10Stelzer KJ. Epidemiology and prognosis of brain metastases [J]. Surg Neurollnt, 2013,4 (Suppl4): S192-S202.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部